Preview

PHARMACOECONOMICS. Modern pharmacoeconomics and pharmacoepidemiology

Advanced search

Browse Title Index


 
Issue Title
 
Vol 7, No 3 (2014) MODELI NG CLINICAL AND ECONOMIC OUTCOMES OF TESTING FOR LTBI WITH T-SPOT.TB IN IMMUNOCOMPROMISED CHILDREN Abstract   PDF (Rus)
V. I. Ignatyeva, M. V. Avxentyeva, V. V. Omelyanovsky, G. R. Khachatryan
 
Vol 7, No 4 (2014) MODELING IN CLINICO-ECONOMIC ANALYSIS OF MEDICAL ORGANIZATIONAL TECHNOLOGIES Abstract   PDF (Rus)
M. A. Shapovalova, A. R. Umerova, V. A. Bondarev, L. R. Koretskaya
 
Vol 11, No 1 (2018) Modeling microbial drug-resistance: from mathematics to pharmacoeconomics Abstract   PDF (Rus)
Yu. M. Gomon, M. A. Arepyeva, Yu. E. Balykina, A. S. Kolbin, A. A. Kurylev, M. A. Proskurin, S. V. Sidorenko
 
Vol 11, No 4 (2018) Modeling the effect of enzyme replacement therapy on life-threatening complications in patients with Fabry disease Abstract   PDF (Rus)
V. I. Ignatyeva, S. V. Moiseev, N. M. Bulanov, E. A. Karovajkina, A S. Moiseev
 
Vol 5, No 1 (2012) MODERNIZATION OF THE MEDICAL SERVICES MARKET Abstract
A. U. Kulikov
 
Vol 9, No 3 (2016) MONITORING OF CONSUMER ATTITUDES TO MEDICINES Abstract   PDF (Rus)
N. B. Dremova, N. P. Yaroshenko, N. I. Afanaseva, S. V. Solomka
 
Vol 8, No 3 (2015) NON-ALCOHOLIC FATTY LIVER DISEASE OUTCOMES FUNNEL Abstract   PDF (Rus)
D. V. Blinov
 
Vol 11, No 3 (2018) Ocrelizumab – a monoclonal antibody – in the treatment of adult patients with multiple sclerosis: a systematic review Abstract   PDF (Rus)
D. L. Klabukova, M. E. Holownia-Voloskova, M. V. Davydovskaya, T. N. Ermolaeva, K. I. Polyakova, A. G. Fisun, K. A. Kokushkin
 
Vol 11, No 1 (2018) Options to optimize the access to biosimilars: analysis and solutions Abstract   PDF (Rus)
O. V. Kirsanova, V. V. Omelyanovsky
 
Vol 8, No 3 (2015) ORGANIZATION AND ANALYSIS OF THE COMMISSION'S WORK ON THE SELECTION AND REFERRAL OF PATIENTS IN A MEDICAL INSTITUTION FOR TREATMENT USING ASSISTED REPRODUCTIVE TECHNOLOGIES ON THE TERRITORY OF THE CHELYABINSK REGION Abstract   PDF (Rus)
M. G. Moskvicheva, V. V. Saharova, Yu. A. Semenov, E. V. Orehova
 
Vol 7, No 2 (2014) PARAMETERS OF HEALTH CARE SYSTEMS Abstract   PDF (Rus)
V. V. Omelyanovskiy, I. V. Maksimova, A. P. Tatarinov
 
Vol 7, No 1 (2014) PATIENTS WITH NEUROLOGICAL DISEASES: RATIONALE FOR PHARMACOECONOMIC EVALUATION OF COST OPTIMIZATION FOR MANAGEMENT WITH NEURON-SPECIFIC PROTEINS ASSESSMENT AS MARKERS OF INCREASED BLOOD-BRAIN-BARRIER PERMEABILITY Abstract   PDF (Rus)
D. V. Blinov
 
Vol 8, No 1 (2015) PAYMENT OF NEW EXPENSIVE TECHNOLOGIES IN HEALTH CARE ON THE BASIS OF RISKS -SHARING AGREEMENTS: POSSIBILITIES OF APPLICATION IN THE RUSSIAN FEDERATION Abstract   PDF (Rus)
L. S. Melnikova
 
Vol 10, No 1 (2017) PERAMPANEL EFFECTIVENESS IN THE TREATMENT OF REFRACTERY PARTIAL ONSET EPILEPSY WITH OR WITHOUT SECONDARY GENERALIZATION: PHARMACOECONOMIC ANALYSIS FOR THE RUSSIAN FEDERATION HEALTH CARE SYSTEM Abstract   PDF (Rus)
N. K. Mazina, I. V. Sheshunov, P. V. Мazin, Yu. V. Kislitsin, E. M. Markova
 
Vol 5, No 1 (2012) PHA RMA COE CONOMI CAL EVALUATION OF MULTIPLE MYELOMA TREATMENT WITH REVLIMID (LENALIDOMIDE ) IN THE RUSSIAN FEDE RATION Abstract
R. Yagudina, A. Kulikov, B. Misikova
 
Vol 6, No 4 (2013) Pharmacoeconomic analysis of Anti-inhibitor coagulant complex (AICC) in the treatment of inhibitor hemophilia Abstract
R. I. Yagudina, I. Yu. Zinchuk
 
Vol 6, No 4 (2013) Pharmacoeconomic analysis of blood glucose meter Contour TS in diabetes treatment Abstract
A. U. Kulikov, V. V. Babiy
 
Vol 10, No 1 (2017) PHARMACOECONOMIC ANALYSIS OF BRENTUXIMAB VEDOTIN THERAPY IN RELAPSED OR REFRACTORY CD30+ SYSTEMIC ANAPLASTIC LARGE CELL LYMPHOMA IN PATIENTS OVER 18 YEARS OF AGE: HEALTH BUDGET IMPACT ANALYSIS Abstract   PDF (Rus)
A. S. Kolbin, I. A. Vilum, М. A. Proskurin, Yu. E. Balykina
 
Vol 9, No 2 (2016) PHARMACO-ECONOMIC ANALYSIS OF COST IN TERMS OF MAINTENANCE OF PREFERENTIAL MEDICINES PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE ON THE TERRITORY OF KRASNOYARSK REGION Abstract   PDF (Rus)
T. V. Gaygolnik, I. V. Demko, E. N. Bochanova, A. Yu. Kraposhina, N. V. Gordeeva, I. A. Soloveva
 
Vol 6, No 3 (2013) PHARMACOECONOMIC ANALYSIS OF DOCETAXEL IN THE ADJUVANT THERAPY OF BREAST CANCER Abstract
R. I. Yagudina, I. Yu. Zinchuk
 
Vol 8, No 1 (2015) PHARMACOECONOMIC ANALYSIS OF EVEROLIMUS IMMUNOSUPRESSIVE THERAPY AFTER RENAL TRANSPLANTATION Abstract   PDF (Rus)
M. V. Avxentyeva, N. A. Avxentyev, M. Yu. Frolov, E. V. Derkach
 
Vol 6, No 4 (2013) Pharmacoeconomic analysis of fluid therapy in the treatment of patients with peritonitis Abstract
R. I. Yagudina, M. M. Murashko
 
Vol 6, No 3 (2013) PHARMACOECONOMIC ANALYSIS OF NEUROPROTECTIVE DRUGS IN THE TREATMENT OF ACUTE DISORDERS OF CEREBRAL CIRCULATION Abstract
A. Yu. Kulikov, I. Yu. Zinchuk
 
Vol 9, No 2 (2016) PHARMACOECONOMIC ANALYSIS OF THE THERAPY OF СHRONIC OBSTRUCTIVE PULMONARY DISEASE PATIENTS IN HOSPITAL CONDITIONS Abstract   PDF (Rus)
E. E. Vidyakina, S. V. Malchikova
 
Vol 7, No 3 (2014) PHARMACOECONOMIC ANALYSIS OF THE USE OF OXALIPLATIN CHEMOTHERAPY FOR COLORECTAL CANCER.REAL (ACTUAL) CLINICAL PRACTICE DATA Abstract   PDF (Rus)
A. V. Pavlysh, A. S. Kolbin, A. R. Kasimova
 
101 - 125 of 225 Items << < 1 2 3 4 5 6 7 8 9 > >>